Kyverna Therapeutics, Inc. KYTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s invested capital?
- Kyverna Therapeutics, Inc. (KYTX) reported invested capital of $172.55M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s invested capital changed year-over-year?
- Kyverna Therapeutics, Inc.'s invested capital decreased by 0.9% year-over-year, from $174.08M to $172.55M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s invested capital?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s invested capital has grown at a 70.7% compound annual growth rate (CAGR), from -$38.71M to $112.78M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).